Less Typical Cardomyopathies
Oct 8, 2021 1:30pm ‐ Oct 8, 2021 2:15pm
Identification: A-15
Learning Objective:
- 1. Discuss evaluation and management of infiltrative and genetic cardiomyopathies 2. Describe evaluation and management strategies for hypertrophic cardiomyopathy
Cardiac Echo Images, Cases – Less Typical /Peri-Partum/MRIs
Oct 8, 2021 2:15pm ‐ Oct 8, 2021 3:00pm
Identification: A-16
Learning Objective:
- 1. Identify the major structures (chambers and valves) in ultrasound images of the heart. 2. Recognize and describe the standard views of transthoracic cardiac ultrasound and identify the utility of each view. 3. Review the role of echocardiography in the diagnosis and management of heart failure patients (systolic and diastolic dysfunction). 4. Discuss clinical situations that outline the use of this diagnostic study. 5. Review the most recent ACCF/AHA & HFSA Heart Failure Guidelines for the use of echocardiography in heart failure patients
Covid-19 and Cardiomyopathy
Oct 8, 2021 3:00pm ‐ Oct 8, 2021 3:30pm
Identification: A-17
Learning Objective:
- 1. The participant will describe methods for diagnosing COVID-19 associated myocarditis. 2. The participant will list at least 2 interventions for the management of COVID-19 associated myocarditis. 3. The participant will explain the relationship between m-RNA COVID-19 vaccines and myocarditis
New FDA Approved Thearpies
Oct 8, 2021 3:30pm ‐ Oct 8, 2021 4:00pm
Identification: A-18
Learning Objective:
- 1. Discuss the evidence for the use of SGLT2 inhibitors in the management of heart failure 2. Review the clinical evidence for the use of soluble guanylate cyclase stimulator in the management of heart failure 3. Describe therapies on the horizon in clinical trial for heart failure
Industry Presentation Sponsored by AstraZeneca A Treatment Option for Patients with Heart Failure with Reduced Ejection Fraction
Oct 8, 2021 4:00pm ‐ Oct 8, 2021 5:15pm
Identification: A-18A
How to Recognize Shock/Temp Devices
Oct 9, 2021 8:15am ‐ Oct 9, 2021 9:00am
Identification: A-22
Learning Objective:
- 1. The participant will know the signs of Cardiogenic Shock. 2. The participant will identify the categories of Cardiogenic Shock. 3. The participant will understand the temporary devices used to care for the patient in Cardiogenic Shock.
